FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

The Associated Press on MSN · 12h

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Time on MSN · 11h

FDA Approves the First Non-Opioid Pain Drug in 20 Years

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.

Ozempic receives FDA nod for treating chronic kidney disease

CNN on MSN · 2d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

U.S. News & World Report · 1d

FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes

Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh

Hosted on MSN · 1d

Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk

The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug, showed a reduced risk of kidney failure. Experts explain how the drug helps.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 1d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

Fortune on MSN · 1d

FDA reclassifies Lay’s potato chips recall to the highest risk level, warning the chips could cause ‘serious adverse health consequences or death’

The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could cause death. The chips were originally recalled last month for containing undeclared milk.

USA Today · 1d

Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?

The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.

STAT2h

How to protect HHS, FDA, NIH, and other health agencies from political interference

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

16h

US FDA Identifies Cybersecurity Risks in Certain Patient Monitors

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...

13h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

The New Republic on MSN51m

The Right Is Frothing Over a New Medication Abortion Study

When people talk about “the abortion pill,” they typically mean mifepristone, the first drug in the FDA-approved medication abortion regimen. Conservatives are currently lobbying both federal courts ...

New Atlas2h

"Kick and kill": HIV cure could be hiding in FDA-approved drug

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Opinion

Williamsport Sun-Gazette4hOpinion

What other newspapers are saying: Pharmacy benefit practices must be reformed

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

Ozempic receives FDA nod for treating chronic kidney disease

FDA upgrades recall of Lay's potato chips

Related topics